Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

814
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
814
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

750
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
750
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

3.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.7K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

545
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
545
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

633
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
633

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Progressive Versus Standard Implant Thread Designs on Primary Stability and Insertion Torque: An In Vitro Study.

The International journal of oral & maxillofacial implants·2026
Same author

The impact of free radicals on opioid receptors in tissue injury and inflammation: implications for drug design.

Expert opinion on drug discovery·2026
Same author

Physical activity and psychosocial characteristics of individuals with and without chronic low back pain in daily life: protocol for the PRIA intensive longitudinal study.

BMJ open·2025
Same author

Psychological risk factors and resources for low back pain intensity and back health in daily life: An ecological momentary assessment study.

Applied psychology. Health and well-being·2025
Same author

Detailed Analysis of Back Pain: A Cross-Sectional Study of Epidemiology and Previous Therapies in a German Population.

Pain practice : the official journal of World Institute of Pain·2025
Same author

A pH-sensitive opioid does not exhibit analgesic tolerance in a mouse model of colonic inflammation.

British journal of pharmacology·2024

Related Experiment Video

Updated: Dec 23, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

33.9K

Opioid analgesia: recent developments.

Christoph Stein1

  • 1Department of Experimental Anaesthesiology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin.

Current Opinion in Supportive and Palliative Care
|April 19, 2020
PubMed
Summary
This summary is machine-generated.

Novel analgesics are urgently needed to manage severe pain without the detrimental side effects of traditional opioids. Research focuses on enhancing the body's natural pain relief and targeting peripheral opioid receptors for safer pain management.

More Related Videos

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.7K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.7K

Related Experiment Videos

Last Updated: Dec 23, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

33.9K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.7K
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.7K

Area of Science:

  • Pharmacology
  • Pain Management
  • Drug Development

Background:

  • Opioids are effective for severe pain but cause significant side effects like addiction and respiratory depression.
  • Their use in chronic non-malignant pain is controversial and linked to the opioid crisis.
  • There is a critical need for novel analgesics with improved safety profiles.

Purpose of the Study:

  • To review current research and future perspectives in the development of novel analgesics.
  • To explore strategies for mitigating the adverse effects associated with opioid therapy.
  • To identify promising therapeutic targets for pain management.

Main Methods:

  • Review of current research topics in analgesic development.
  • Analysis of novel pharmacological insights into pain pathophysiology.
  • Examination of clinical studies on selective opioid receptor agonists.

Main Results:

  • Current research explores enkephalinase inhibitors, biased opioid receptor signaling, and peripheral opioid receptor activation.
  • Augmenting endogenous opioid actions and targeting peripheral receptors are promising strategies.
  • Several novel drug candidates have reached Phase III trials, but none are yet clinically available.

Conclusions:

  • Opioid-based approaches remain promising for analgesic development.
  • Selective targeting of peripheral opioid receptors shows clinical support.
  • Future analgesic drug development may benefit from public-private partnerships and non-profit initiatives.